Increased levels of IL-4 in the Spleen of BALB/c Mice after 65.5 kDa Pili Protein Klebsiella pneumoniae Immunization
DOI:
https://doi.org/10.31964/mltj.v10i1.575Keywords:
Interleukin-4, Klebsiella pneumoniae, pili, vaccineAbstract
Pneumonia is an infection of the lung parenchyma caused by Klebsiella pneumoniae, resulting in a high mortality rate of millions each year. To reduce these deaths, one potential solution is to create a vaccine that utilizes virulence factors of this microorganism, such as pili. During the early phase of infection, these antigens have a crucial role and can stimulate the production of memory b cells. These cells are activated by IL-4 (interleukin-4) in lymphoid organs, such as the spleen. Pathogen exposure such as virulence factors can stimulate the secretion of IL-4 in the spleen organ. This study aims to investigate the role of Klebsiella pneumoniae pili in this process. The research conducted from May to December 2023 at the Microbiology Laboratory, Faculty of Medicine, University of Jember was purely experimental, using Balb/c mice with IL-4 levels in the spleen organ as variables. The study used 15 mice, divided into control (K1), adjuvant (K2), and antigen (K3) groups. The research data were analyzed using non-parametric tests, specifically the Kruskal-Wallis and Post Hoc tests. The Kruskal-Wallis test revealed significant differences (p=0.003). In the Post Hoc test, a significant difference was found between the control and antigen groups (p=0.002). The results conclusively demonstrate that induction of Klebsiella pneumoniae pili protein 65.5 kDa significantly increases IL-4 levels in the spleen. Future studies should consider adding serum specimens to provide additional information.References
Agustina, D., & Mufida, D. C. (2021). Immunodetection of Adhesin Pili Protein 38.6 kDa K. pneumoniae Using Western Blot. Journal of Islamic Science and Technology Vol. 7, No. 2, 7(2), 317–327. https://doi.org/10.22373/ekw.v7i2.10127
Agustina, D., Wati, M. L., Wisudanti, D. D., Shodikin, M. A., Mufida, D. C., & Suswati, E. (2022). Pili Protein 65.5 kDa of Klebsiella pneumoniae Induced a Decrease in IL-10 in Mice. Majalah Kedokteran Bandung, 54(3), 143–147. https://doi.org/10.15395/mkb.v54n3.2690
Arato, V., Raso, M. M., Gasperini, G., Scorza, F. B., & Micoli, F. (2021). Prophylaxis and treatment against Klebsiella pneumoniae: Current insights on this emerging anti-microbial resistant global threat. International Journal of Molecular Sciences, 22(8). https://doi.org/10.3390/ijms22084042
Arifin, W. N., & Zahiruddin, W. M. (2017). Sample Size Calculation in Animal Studies Using Resource Equation Approach. 24(5), 101–105.
Chang, D., Sharma, L., Cruz, C. S. D., & Zhhang, D. (2021). Clinical epidemiology , risk factors , and control strategies of Klebsiella pneumoniae infection. Frontiers in Microbiology, 12, 1–9. https://doi.org/10.3389/fmicb.2021.750662
Choi, M., Tennant, S. M., Simon, R., & Cross, A. S. (2020). Progress towards the development of Klebsiella vaccines. HHS Public Access, 18(7), 681–691. https://doi.org/10.1080/14760584.2019.1635460.Progress
Darwin, E., Elvira, D., & Elfi, E. F. (2021). Imunologi dan Infeksi. Andalas University Press.
Ejikeme, C., Nwachukwu, O., Ayad, S., Rath, P., Ejikeme, I., & Salamera, J. (2021). Hepatosplenic Abscess From Klebsiella pneumoniae in Poorly Controlled Diabetic. Journal of Investigative Medicine High Impact Case Reports, 9, 4–7. https://doi.org/10.1177/23247096211033046
Fan, J., Jin, S., Gilmartin, L., Toth, I., Hussein, W. M., & Stephenson, R. J. (2022). Advances in Infectious Disease Vaccine Adjuvants. Vaccines, 10(7). https://doi.org/10.3390/vaccines10071120
Greenfield, E. A. (2019). Preparing and Using Adjuvants. Cold Spring Harbor Laboratory Press, 73–79. https://doi.org/10.1101/pdb.prot100214
Greenfield, E. A. (2020). Standard Immunization of Mice , Rats , and Hamsters. Cold Spring Harbor Laboratory Press, 82–85. https://doi.org/10.1101/pdb.prot100297
Hu, G., Chen, X., Chu, W., Ma, Z., Miao, Y., Luo, X., & Fu, Y. (2022). Immunogenic characteristics of the outer membrane phosphoporin as a vaccine candidate against Klebsiella pneumoniae. Veterinary Research, 1–13. https://doi.org/10.1186/s13567-022-01023-2
IAUCC. (2023). Anesthesia (Guideline). https://animal.research.uiowa.edu/iacuc-guidelines-anesthesia
Lee, W., Choi, H., Hong, S., Kim, K., Gho, Y. S., & Jeon, S. G. (2015). Vaccination with Klebsiella pneumoniae -derived extracellular vesicles protects against bacteria-induced lethality via both humoral and cellular immunity. 47. https://doi.org/10.1038/emm.2015.59
Lewis, S. M., Williams, A., Eisenbarth, S. C., Haven, N., Haven, N., & Sciences, G. (2019). Structure-function of the immune system in the spleen Steven. HHS Public Access, 4(33), 1–25. https://doi.org/10.1126/sciimmunol.aau6085.Structure-function
Manuaba, I. A. S. P., Iswari, I. S., & Pinatih, K. J. P. (2021). Prevalensi bakteri Escherichia coli dan Klebsiella pneumoniae penghasil extended spectrum beta lactamase (ESBL) yang diisolasi dari pasien pneumonia RSUP Sanglah periode tahun 2019-2020. Jurnal Medika Udayana, 10(12), 51–57.
Martin, R. M., & Bachman, M. A. (2018). Colonization, Infection, and the Accessory Genome of Klebsiella pneumoniae. 8, 1–15. https://doi.org/10.3389/fcimb.2018.00004
Moser, E. K., Field, N. S., & Oliver, P. M. (2018). Aberrant Th2 inflammation drives dysfunction of alveolar macrophages and susceptibility to bacterial pneumonia. Cellular and Molecular Immunology, 15(5), 480–492. https://doi.org/10.1038/cmi.2016.69
Nahm, F. S. (2016). Nonparametric Statistical Test For The Continous Data. Korean Journal of Anesthesiology.
Noh, A. S. M., Chuan, T. D., Khir, N. A. M., Zin, A. A. M., Ghazali, A. K., Long, I., Ab Aziz, C. B., & Ismail, C. A. N. (2021). Effects of different doses of complete Freund’s adjuvant on nociceptive behaviour and inflammatory parameters in polyarthritic rat model mimicking rheumatoid arthritis. PLoS ONE, 16, 1–24. https://doi.org/10.1371/journal.pone.0260423
Poerio, N., Olimpieri, T., Henrici De Angelis, L., De Santis, F., Thaller, M. C., D’Andrea, M. M., & Fraziano, M. (2022). Fighting MDR-Klebsiella pneumoniae Infections by a Combined Host- and Pathogen-Directed Therapeutic Approach. Frontiers in Immunology, 13, 1–6. https://doi.org/10.3389/fimmu.2022.835417
Pollard, A. J., & Bijker, E. M. (2021). A guide to vaccinology: from basic principles to new developments. Nature Reviews Immunology, 21(2), 83–100. https://doi.org/10.1038/s41577-020-00479-7
Sirat, D. (2021). Pengaruh pemberian imunomodulator jintan hitam (Nigella sativa) terhadap titer antibodi avian influenza dan newcastle disease pada broiler jantan. Jurnal Riset Dan Inovasi Peternakan, 5(1), 37–42.
Suardana, I. B. K. (2017). Diktat imunologi dasar sistem imun. Universitas Udayana.
Suswati, E., Agustina, D., Shodikin, M. A., Mufida, D. C., Sutejo, I. R., Wisnu, T., Putra, P., Mikrobiologi, D., Kedokteran, F., & Jember, U. (2022). Kadar Sekresi IL-10 Hepar Mencit Galur BALB / c Setelah Pemberian Protein Pili 65,5 kDa Klebsiella pneumoniae. Jurnal Biotek Medisian Indonea, 161–171.
Widiatmaja, D. T., Mufida, D. C., & Febianti, Z. (2021). Pengaruh Pemberian Imunisasi Intranasal Epitope Protein RrgB 255-270 Streptococcus pneumoniae Terhadap Kadar IL-4. Sriwijaya Journal of Medicine, 4, 0–6. https://doi.org/10.32539/SJM.v4i1.155
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Diana Chusna Mufida, Diego Rafi Putra Uta, Ika Rahmawati Sutejo, Dini Agustina, Enny Suswati, Muhammad Ali Shodikin
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Publishing your paper with Medical Laboratory Technology Journal (MLTJ) means that the author or authors retain the copyright in the paper. MLTJ granted an author(s) rights to put the paper onto a website, distribute it to colleagues, give it to students, use it in your thesis etc, even commercially. The author(s) can reuse the figures and tables and other information contained in their paper published by MLTJ in future papers or work without having to ask anyone for permission, provided that the figures, tables or other information that is included in the new paper or work properly references the published paper as the source of the figures, tables or other information, and the new paper or work is not direct at private monetary gain or commercial advantage.
MLTJ journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. This journal is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets others remix, transform, and build upon the material for any purpose, even commercially. MLTJ journal Open Access articles are distributed under this Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA). Articles can be read and shared for All purposes under the following conditions:
BY: You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.SA: If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.